Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christy S John

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|March 31, 2017
Myasthenia GravisSabina Miranda, Derrece K Reid, Christy S John
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical resultsVicky Caveliers, Hendrik Everaert, Christy S John, et al.
Expert Opinion on Drug Delivery|August 27, 2016
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guideTal Burt, Christy S John, Jon L Ruckle, et al.
The Oncologist|April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaKelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|March 31, 2017
Myasthenia GravisSabina Miranda, Derrece K Reid, Christy S John
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2002
Sigma receptor scintigraphy with N-[2-(1'-piperidinyl)ethyl]-3-(123)I-iodo-4-methoxybenzamide of patients with suspected primary breast cancer: first clinical resultsVicky Caveliers, Hendrik Everaert, Christy S John, et al.
Expert Opinion on Drug Delivery|August 27, 2016
Phase-0/microdosing studies using PET, AMS, and LC-MS/MS: a range of study methodologies and conduct considerations. Accelerating development of novel pharmaceuticals through safe testing in humans - a practical guideTal Burt, Christy S John, Jon L Ruckle, et al.
The Oncologist|April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaKelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.
Pageof 1